Regulation of the AGEs-induced inflammatory response in human periodontal ligament cells via the AMPK/NF-κB/ NLRP3 signaling pathway

Exp Cell Res. 2024 Apr 1;437(1):113999. doi: 10.1016/j.yexcr.2024.113999. Epub 2024 Mar 16.

Abstract

The heightened prevalence and accelerated progression of periodontitis in individuals with diabetes is primarily attributed to inflammatory responses in human periodontal ligament cells (HPDLCs). This study is aimed at delineating the regulatory mechanism of nucleotide-binding oligomerization domain-like receptors (NLRs) in mediating inflammation incited by muramyl dipeptide (MDP) in HPDLCs, under the influence of advanced glycation end products (AGEs), metabolic by-products associated with diabetes. We performed RNA-seq in HPDLCs induced by AGEs treatment and delineated activation markers for the receptor of AGEs (RAGE). It showed that advanced glycation end products modulate inflammatory responses in HPDLCs by activating NLRP1 and NLRP3 inflammasomes, which are further regulated through the NF-κB signaling pathway. Furthermore, AGEs synergize with NOD2, NLRP1, and NLRP3 inflammasomes to augment MDP-induced inflammation significantly.

Keywords: AGEs; Inflammation; NF-κB; NLRP inflammasomes; Periodontitis.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Diabetes Mellitus*
  • Glycation End Products, Advanced / pharmacology
  • Humans
  • Inflammasomes / metabolism
  • Inflammation
  • NF-kappa B* / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / genetics
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Periodontal Ligament / metabolism
  • Signal Transduction

Substances

  • NF-kappa B
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Inflammasomes
  • AMP-Activated Protein Kinases
  • Glycation End Products, Advanced